← Back to Search

Polyphenol

Resveratrol for Chronic Obstructive Pulmonary Disease

N/A
Waitlist Available
Led By Paula Rodriguez Miguelez, PhD
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights

Study Summary

This trial is exploring whether the sub-chronic use of resveratrol can help improve cardiovascular health in patients with COPD.

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Sirt1 concentrations
Change in Systemic Inflammation
Change in vascular health
Secondary outcome measures
Change in Inflammatory activation
Change in Nitric Oxide metabolism

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: ResveratrolActive Control1 Intervention
500 mg of time released micronized trans-Resveratrol
Group II: PlaceboPlacebo Group1 Intervention
Placebo will be used in the form of an empty white colored soft vegetarian capsule as resveratrol is presented

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor
698 Previous Clinical Trials
22,884,969 Total Patients Enrolled
Paula Rodriguez Miguelez, PhDPrincipal InvestigatorVirginia Commonwealth University
2 Previous Clinical Trials
93 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the sample size of this investigation?

"Yes, the data on clinicaltrials.gov verifies that this investigation is presently enlisting patients. The study was first posted on July 1st 2019 and last updated by July 22nd 2022. Currently, 48 participants are needed to be recruited at one medical centre."

Answered by AI

Is the intake process still ongoing for this research project?

"Affirmative. Evidence displayed on clinicaltrials.gov affirms that a current search for participants is being conducted, with the trial first posted on July 1st 2019 and last updated on July 22nd 2022. This study requires 48 patients to be found at one medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
65+
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Improving Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease
2019. "Improving Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03819517.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top